Component: (Network and Table)
Network
00100 - Statement - CONDENSED BALANCE SHEETS
(http://www.corvuspharma.com/role/StatementCondensedBalanceSheets)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0001626971 (http://www.sec.gov/CIK)
CONDENSED BALANCE SHEETSPeriod [Axis]
2016-12-31
2015-12-31
CONDENSED BALANCE SHEETS
 
 
Assets
 
 
Current assets:
 
 
Cash and cash equivalents
5,050,000  
4,105,000  
Marketable securities
129,846,000  
90,281,000  
Prepaid and other current assets
1,137,000  
1,277,000  
Total current assets
136,033,000  
 
95,663,000  
 
Property and equipment, net
3,248,000  
1,845,000  
Deferred offering costs
 
951,000  
Other assets
869,000  
 
Total assets
140,150,000  
 
98,459,000  
 
Liabilities, Convertible Preferred Stock, and Stockholders' Equity (Deficit)
 
 
Current liabilities:
 
 
Accounts payable
1,900,000  
1,575,000  
Accrued and other liabilities
4,044,000  
1,495,000  
Convertible preferred stock liability
  
Total current liabilities
5,944,000  
 
3,070,000  
 
Other liabilities
1,405,000  
710,000  
Total liabilities
7,349,000  
 
3,780,000  
 
Commitments and contingencies (Note 13)
xsi:nil  
xsi:nil  
Convertible preferred stock: $0.0001 par value; 0 and 14,274,741 shares authorized at December 31, 2016 and December 31, 2015, respectively; 0 and 14,274,741 issued and outstanding at December 31, 2016 and December 31, 2015, respectively
 
125,780,000  
Stockholders' equity (deficit):
 
 
Preferred stock: $0.0001 par value; 10,000,000 and 0 shares authorized at December 31, 2016 and December 31, 2015, respectively; 0 shares issued and outstanding at December 31, 2016 and December 31, 2015
xsi:nil  
xsi:nil  
Common stock: $0.0001 par value; 290,000,000 and 20,000,000 shares authorized at December 31, 2016 and 2015, respectively; 20,922,428 and 1,431,615 shares issued and outstanding at December 31, 2016 and 2015 respectively
2,000  
 
Additional paid-in capital
200,709,000  
440,000  
Accumulated other comprehensive income (loss)
(39,000) 
(45,000) 
Accumulated deficit
(67,871,000) 
(31,496,000) 
Total stockholders' equity (deficit)
132,801,000  
 
(31,101,000) 
 
Total liabilities, convertible preferred stock and stockholders' equity (deficit)
140,150,000  
 
98,459,000